Archive for Profitability
NEW Members’ Resource: Category H Updates
For Category H Updates and Dispex Insights to assist you in purchasing products for this new Category click here to view. Scroll to the bottom of the page to see...
Turn your dispensary data into profit.
Category M Misery…again – An unwelcome start the new year
Another big reduction in Category M prices will be an unwelcome start to the new year. In addition, the DHSC will be reducing Category A prices to claw back some...
Dispex Nudger Update
Many of you have already started using the Dispex Nudger, and we’re pleased to share that new templates have now been added…….. If you’ve not yet explored the Nudger,...
Innovating with e-CASS
Dispex is now working in collaboration with Cambrian Alliance to enhance the already great advantages of using e-CASS as a single ordering portal. Click here to find out more.
A NEW Brand Comparisons Page
Nutritional Sips- Flavour of the Month We’ve just published a NEW Brand Comparisons section on the Dispex website for Nutritional Sips. Members can click here to login & view. Looking...
A Small Increase – Dispensing Fee Scale
By Dispex There has been a small increase in the Dispensing Fees, which will amount to an average 8 pence per item more. Practices are reminded that the scale relates...
Announcing a new partnership with e-CASS
We are pleased to announce that Dispex is now working in collaboration with e-CASS to ensure our Dispex members enhance the already great advantages of using e-CASS as your single...
AstraZeneca – Forxiga – Clarification
From pack 1 each month there will be 30% discount, which works out as costing £25.61 for the first 20 and there will be 40% discount thereafter, which works out...
Keeping Your Dispensary Informed:
Brand Comparisons, Profitability Insights & Top Tips from Dispex Are you staying ahead of the changes? At Dispex, we continually monitor changes within the dispensing world, updating our brand comparison...
Diabetes – Glucagon-like Peptide-1 receptor Agonists (GLP1)
By Dispex More and more patients are being started on GLP1 agonists in an attempt to bring their diabetes and weight under control. There are 7 injectable brands, as well...
Manufacturers Rebate Scheme Changes
By Dr Philip Koopowitz – Director Dispex MDS, RWA, QE and now ePACT Over the past month we have seen 2 manufacturers move the way they deal with rebates away...
